Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spark

Showing results (311-320 of 331) with videos related to

Pageof 34
Sort By:
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 6, 2023
Differential Expression of Anomalous Self-Experiences in Spontaneous Speech in Clinical High-Risk and Early-Course Psychosis Quantified by Natural Language ProcessingAgrima Srivastava, Alexandria Selloni, Zarina R Bilgrami, et al.
Early Intervention in Psychiatry|January 7, 2026
Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United StatesDaniel I Shapiro, Rebecca E Grattan, Jill R Laquidara, et al.
NPP - Digital Psychiatry and Neuroscience|March 24, 2025
"Ask" or "Inquire": operationalizing speech formality in psychosis and its risk states using etymologyMatthew Cotter, Alessia McGowan, Zarina Bilgrami, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stabilityPatrick S Johnson, Thomas Ryckmans, Justin Bryans, et al.
Schizophrenia Research|February 2, 2023
The SPEAK study rationale and design: A linguistic corpus-based approach to understanding thought disorderJ M M Bayer, J Spark, M Krcmar, et al.
Journal of the American Heart Association|November 15, 2024
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older PeopleSophia Zoungas, Chris Moran, Andrea J Curtis, et al.
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
Psychiatry Research|May 29, 2024
Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosisMelissa Collins, Cali Bartholomeusz, Cristina Mei, et al.
Schizophrenia Bulletin|September 6, 2024
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11Paul Møller, Barnaby Nelson, Patrick D McGorry, et al.
JAMA Psychiatry|June 28, 2023
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized TrialPatrick D McGorry, Cristina Mei, G Paul Amminger, et al.
Pageof 34

Showing results (311-320 of 331) with videos related to

Sort By:
Pageof 34
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 6, 2023
Differential Expression of Anomalous Self-Experiences in Spontaneous Speech in Clinical High-Risk and Early-Course Psychosis Quantified by Natural Language ProcessingAgrima Srivastava, Alexandria Selloni, Zarina R Bilgrami, et al.
Early Intervention in Psychiatry|January 7, 2026
Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United StatesDaniel I Shapiro, Rebecca E Grattan, Jill R Laquidara, et al.
NPP - Digital Psychiatry and Neuroscience|March 24, 2025
"Ask" or "Inquire": operationalizing speech formality in psychosis and its risk states using etymologyMatthew Cotter, Alessia McGowan, Zarina Bilgrami, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stabilityPatrick S Johnson, Thomas Ryckmans, Justin Bryans, et al.
Schizophrenia Research|February 2, 2023
The SPEAK study rationale and design: A linguistic corpus-based approach to understanding thought disorderJ M M Bayer, J Spark, M Krcmar, et al.
Journal of the American Heart Association|November 15, 2024
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older PeopleSophia Zoungas, Chris Moran, Andrea J Curtis, et al.
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
Psychiatry Research|May 29, 2024
Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosisMelissa Collins, Cali Bartholomeusz, Cristina Mei, et al.
Schizophrenia Bulletin|September 6, 2024
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11Paul Møller, Barnaby Nelson, Patrick D McGorry, et al.
JAMA Psychiatry|June 28, 2023
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized TrialPatrick D McGorry, Cristina Mei, G Paul Amminger, et al.
Pageof 34